IPQ Inside the global regulatory dialogue

FDA Data Integrity Concerns Continue in India as Three More Firms Draw GMP Warning Letters

Aug 22nd, 2013

Please Log in to print the full article

Three warning letters recently issued on findings at facilities in India indicate FDA’s continued focus on data integrity as a central concern of its international inspection program – and in the Indian arena, in particular.......

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications